Abstract
Purpose :
To analyze the epidemiological profile of patients that underwent evisceration or enucleation at an ophthalmological emergency room sector of a brazilian tertiary hospital in the last 7 years.
Methods :
This study is a retrospective analysis of the cases treated in the ophthalmological emergency room from the Sao Paulo Hospital (Federal University of Sao Paulo) between the years of 2012 to 2018. We included the emergency cases of evisceration or enucleation and excluded the elective cases. We analyzed the medical records of patients that came to this service and collected demographic data, informations about the immediate causes for the procedure, associated causes, informed visual acuity, time of onset symptoms until search for medical care, distance from the residence to the tertiary hospital and time of hospitalization.
Results :
A total of 73 enucleations (40 men and 33 women) and 120 eviscerations (60 men and 60 women) were included in our study. The mean age was 63.36 years (0-95). The evisceration or enucleation immediate causes were: perforated corneal ulcer (31%), painful blind eye (24%), ocular trauma (21%), endophthalmitis (20%), intraocular neoplasia (1.5%) and phthisis (0.5%). The reported visual acuity was absence of light perception (85.5%), light perception (4.6%), hand motion (1%) and non-informant (1.5%). The mean time taken to seek ophthalmologic care was 10 days (1-150), the mean distance between home and unit care was 30.3 kilometers (2.2-653) and the mean duration of hospital stay was 3 days (0-41).
Conclusions :
Ocular enucleation and evisceration are procedures reserved for cases without visual prognosis. Our study is the first to analyze epidemiological data on ocular enucleation and evisceration in an ophthalmological emergency service of a brazilian tertiary hospital. The main causes were corneal involvement, painful blind eyes, ocular trauma and endophthalmitis. This study guides possible preventive measures for the main indications of evisceration and enucleation and the reserved prognosis in advanced cases of such ocular pathologies.
This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.